Now online: SABCS today 2021 – the licensed reporting from SABCS 2021
17.02.2022 13:56
SABCS today covered the latest results of breast cancer research, which were presented at the San Antonio Breast Cancer Symposium 2021, in highlight sessions on six topic areas by leading experts. Since December 10th, all contributions and the associated slides have been available as on-demand videos on www.medtoday.de.
This year's hybrid event attracted many people to San Antonio to experience the symposium in person, despite the ongoing COVID-19 pandemic. In addition, the virtual environment of the symposium also enabled our speakers participating online to exchange and discuss the latest status of breast cancer research.
These experts presented the study highlights of the SABCS 2021:
- Prof. Dr. med. Peter A. Fasching – Personalized breast cancer medicine
Women's Clinic, University Breast Center Franconia, Comprehensive Cancer Center Erlangen-EMN
- Prof. Dr. med. Christian Jackisch – Metastatic breast cancer HR+/HER-2 negative
Director of the Clinic for Gynecology and Obstetrics, Sana Klinikum Offenbach
- PD Dr. med. Rachel Würstlein – Supportive Therapies
Managing senior physician at the breast center, clinic and polyclinic for gynecology and obstetrics, LMU Klinikum, CCC Munich
- Prof. Dr. med. Nadia Harbeck – Metastatic breast cancer HER-2 positive
Head of the Breast Center, Clinic and Polyclinic for Gynecology and Obstetrics, LMU Klinikum, CCC Munich - Prof. Dr. med. Michael Untch – Triple-negative breast cancer
Chief physician of the women's clinic, head of the interdisciplinary breast center and the certified center for gynecological oncology, HELIOS Klinikum Berlin-Buch
- Univ.-Prof. Dr. med. Wolfgang Janni – Breast cancer adjuvant and neoadjuvant
Medical director of the women's clinic, Ulm University Hospital
Interested parties can refer to www.medtoday.de Secure access to the entire range of knowledge through a one-time, free registration. There you will find the most relevant and up-to-date information on the latest study results selected by our experts at the world's largest meeting for breast cancer research.
SABCS today 2021 is the licensed reporting of the Best of SABCS News program for Germany.
SABCS today 2021 is made possible with the kind support of AstraZeneca and Daiichi Sankyo.